News & Press Releases

  • 09 October 2017 - PRESSE RELEASE

    Ebola vaccine can now be used on children

    CDC_Ebola_Cynthia_Goldsmith_115.tif

    An international team of researchers has successfully tested a vaccine against the Ebola virus: The clinical trial was led by tropical disease specialists Dr Selidji T. Agnandji from DZIF´s African partner institution “Centre de Recherches Médicales de Lambaréné” in Gabon and DZIF coordinator Professor Peter Kremsner, Institute of Tropical Medicine in Tübingen.more ]

  • 29 September 2017 - PRESS RELEASE

    Andreas Peschel receives the DZIF Prize for Translational Infection Research 2017

    Peschel_116.jpg

    For over 20 years, Professor Andreas Peschel from the Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT) and the German Center for Infection Research (DZIF) has dedicated his research to bacterial infections with Staphylococcus aureus. He has now received this year’s DZIF Prize for Translational Infection Research in honour of his scientific achievements. more ]

  • 14 September 2017 - PRESS RELEASE

    Fighting antibiotic resistance globally: experts meet in Hamburg

    130115-logo-alle

    Infectious diseases are amongst the most frequent causes of death worldwide. Increasing antibiotic resistance currently constitutes a major challenge: drugs which have been effective against infections for years are becoming ineffective. Doctors and scientists from the German Society of Infectious Diseases (DGI) and the German Center for Infection Research (DZIF) will focus on this issue at the joint DGI and DZIF Annual Meeting taking place in Hamburg from 28 to 30 September. more ]

  • 30 August 2017 - PRESS RELEASE

    Ebola: Early immune response provides insight into vaccination

    Ebolaviren_NIAID_116.jpg

    The latest outbreaks of emerging, dangerous pathogens, such as Ebola, MERS-CoV or Zika, emphasise the importance of the rapid development of effective vaccines. However, being able to predict the efficacy of new vaccines is and remains a challenge in vaccine development. DZIF scientists at the Heinrich Pette Institute and the University Medical Centre Hamburg-Eppendorf (UKE) were successful in their study in assessing early on the longer-term immune response in humans after being vaccinated with the newly developed Ebola vaccine “rVSV-ZEBOV“. more ]

  • 18 August 2017 - PRESS RELEASE

    On the way to developing a new active ingredient against chronic infections

    Ps.aeruginosa_CDC_Janice_Haney_Carr_116.jpg

    Chronic lung infections caused by the bacterium Pseudomonas aeruginosa require complex and, in most cases, long-term treatment with antibioticsnew medication is badly needed. Scientists at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and the German Center for Infection Research (DZIF) are now improving an anti-infective active ingredient with a new mode of action. The starting point is a substance that can block the pathogenicity of the bacterium and weaken its protective biofilm. more ]

  • 10 August 2017 - PRESS RELEASE

    New approach to gastritis treatment

    170810_Josenhans_115.jpg

    Scientists from the Hannover Medical School (MHH) have elucidated how Helicobacter pylori causes gastritis. Chronic infections with the globally ubiquitous pathogen can also lead to gastric ulcers and gastric cancer. The DZIF was involved in the study. more ]

  • 18 July 2017 - PRESS RELEASE

    Promising Model for Translational Research

    DZG-Logo_116.jpg

    The German Council of Science and Humanities has given the German Centers for Health Research (DZG) a positive assessment in recognition of the DZG’s outstanding achievements. According to the Council, the DZG are a suitable model to promote translational research in specific areas of disease. In the assessment, the advisory body for the Federal Government and the State Governments (Länder) certified that the six centers play an important role in the German science system and recommended their further development. more ]

  • 13 July 2017 - PRESS RELEASE

    Likely source for global M. chimaera infection identified by whole genome sequencing

    Niemann_115.jpg

    Scientists from a European Consortium reconstructed a global Mycobacterium chimaera outbreak by whole genome sequencing. The report has identified contaminated heater-cooler units as the likely source of Mycobacterium chimaera infection in 21 open-heart surgery patients in Switzerland, Germany, the Netherlands, and the UK, and a further 12 in the USA and Australia.
    more ]

  • 05 July 2017 - PRESS RELEASE

    Molecular "Trojan horses" render infections visible

    Ps.aeruginosa_CDC_Janice_Haney_Carr_116.jpg

    DZIF researchers at the Helmholtz Centre for Infection Research (HZI) develop new agents and methods for the localisation and treatment of multi-resistant bacteria. Molecular probes utilise the iron transport system of bacteria to transport antibacterial agents into the bacterial cell. more ]

  • 03 July 2017 - PRESS RELEASE

    DZIF joins with international partners to train medical staff in Africa

    20170703_Schule_Gesundheitswesen_Gabun_116.jpg

    New health care academy in Gabon will provide doctors and health systems workers for the country and the region.more ]

Results 11 to 20 of total 171